HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy.
Zabalza CV, Adam M, Burdelski C, Wilczak W, Wittmer C, Kraft S, Krech T, Steurer S, Koop C, Hube-Magg C, Graefen M, Heinzer H, Minner S, Simon R, Sauter G, Schlomm T, Tsourlakis MC.
Zabalza CV, et al. Among authors: graefen m.
Oncotarget. 2015 May 20;6(14):12822-34. doi: 10.18632/oncotarget.3431.
Oncotarget. 2015.
PMID: 25825985
Free PMC article.